Detalhe da pesquisa
1.
At-home asthma mortality unchanged despite declining mortality in other settings: US death certificate data (2000-2019).
Ann Allergy Asthma Immunol;
132(2): 216-222, 2024 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37848103
2.
Geographic variation in disease burden among patients with severe persistent asthma in the United States.
Ann Allergy Asthma Immunol;
132(5): 602-609.e4, 2024 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38141810
3.
Efficacy of tezepelumab in patients with evidence of severe allergic asthma: Results from the phase 3 NAVIGATOR study.
Clin Exp Allergy;
53(4): 417-428, 2023 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36507576
4.
Tezepelumab reduces exacerbations across all seasons in patients with severe, uncontrolled asthma (NAVIGATOR).
Ann Allergy Asthma Immunol;
131(5): 587-597.e3, 2023 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37619779
5.
Eosinophil responses during COVID-19 infections and coronavirus vaccination.
J Allergy Clin Immunol;
146(1): 1-7, 2020 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32344056
6.
Abnormal Peyer patch development and B-cell gut homing drive IgA deficiency in Kabuki syndrome.
J Allergy Clin Immunol;
145(3): 982-992, 2020 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31816409
7.
Prenatal and perinatal history in Kabuki Syndrome.
Am J Med Genet A;
182(1): 85-92, 2020 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31654559
8.
Kabuki syndrome: international consensus diagnostic criteria.
J Med Genet;
56(2): 89-95, 2019 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30514738
9.
Defects of B-cell terminal differentiation in patients with type-1 Kabuki syndrome.
J Allergy Clin Immunol;
137(1): 179-187.e10, 2016 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26194542
10.
Lipid Mediators of Allergic Disease: Pathways, Treatments, and Emerging Therapeutic Targets.
Curr Allergy Asthma Rep;
16(7): 48, 2016 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27333777
11.
"RE: Lin JL, et al. 'Immunologic assessment and KMT2D mutation detection in Kabuki syndrome.' Clin Genet. 2015;88(3):255-260".
Clin Genet;
97(3): 538-539, 2020 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32064601
12.
Combined immune deficiency in a patient with a novel NFKB2 mutation.
J Clin Immunol;
34(8): 910-5, 2014 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25205549
13.
Gaps in Care Among Uncontrolled Severe Asthma Patients in the United States.
J Allergy Clin Immunol Pract;
2024 Mar 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38508336
14.
KMT2D regulates activation, localization, and integrin expression by T-cells.
Front Immunol;
15: 1341745, 2024.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38765012
15.
Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma Across Multiple Clinically Relevant Subgroups in the NAVIGATOR Study.
Adv Ther;
2024 May 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38802635
16.
Incremental cost burden among patients with severe uncontrolled asthma in the United States.
J Manag Care Spec Pharm;
29(7): 825-834, 2023 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37404066
17.
KMT2C/D COMPASS complex-associated diseases [KCDCOM-ADs]: an emerging class of congenital regulopathies.
Clin Epigenetics;
12(1): 10, 2020 01 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31924266
18.
Central Diabetes Insipidus in a Patient With NFKB2 Mutation: Expanding the Endocrine Phenotype in DAVID Syndrome.
J Clin Endocrinol Metab;
104(9): 4051-4057, 2019 Sep 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31150062
19.
Intratracheal myriocin enhances allergen-induced Th2 inflammation and airway hyper-responsiveness.
Immun Inflamm Dis;
4(3): 248-62, 2016 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27621809